232 related articles for article (PubMed ID: 1724760)
1. Thermodynamic and kinetic aspects of agonist and antagonist binding to 1,4-dihydropyridine receptors.
Zheng W; Hawthorn M; Triggle DJ
Eur J Pharmacol; 1991 Oct; 208(2):137-47. PubMed ID: 1724760
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the properties of binding of calcium-channel activators and inhibitors to dihydropyridine receptors in chick heart membranes.
Maan AC; Hosey MM
Circ Res; 1987 Sep; 61(3):379-88. PubMed ID: 2441891
[TBL] [Abstract][Full Text] [Related]
3. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
Wei XY; Rutledge A; Triggle DJ
Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
[TBL] [Abstract][Full Text] [Related]
4. Binding of A 1,4-dihydropyridine calcium channel activator, (-) S Bay K 8644, to cardiac preparations.
Ferrante J; Luchowski E; Rutledge A; Triggle DJ
Biochem Biophys Res Commun; 1989 Jan; 158(1):149-54. PubMed ID: 2463833
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel calcium antagonist binding site in rat brain by SR 33557.
Kenny BA; Fraser S; Spedding M
Br J Pharmacol; 1993 Jan; 108(1):93-9. PubMed ID: 7679034
[TBL] [Abstract][Full Text] [Related]
6. Comparative aspects and temperature dependence of [3H]1,4-dihydropyridine Ca2+ channel antagonist and activator binding to neuronal and muscle membranes.
Rampe D; Luchowski E; Rutledge A; Janis RA; Triggle DJ
Can J Physiol Pharmacol; 1987 Jul; 65(7):1452-60. PubMed ID: 2444320
[TBL] [Abstract][Full Text] [Related]
7. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
Maan AC; Ptasienski J; Hosey MM
J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217
[TBL] [Abstract][Full Text] [Related]
8. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
Reynolds IJ; Snowman AM; Snyder SH
J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067
[TBL] [Abstract][Full Text] [Related]
9. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
Lee HR; Roeske WR; Yamamura HI
Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927
[TBL] [Abstract][Full Text] [Related]
10. Photoaffinity labeling with dihydropyridine derivatives of crude membranes from rat skeletal, cardiac, ileal, and uterine muscles and whole brain.
Ichida S; Masada A; Fujisue T; Yoshioka T; Matsuda N
J Biochem; 1989 May; 105(5):767-74. PubMed ID: 2473981
[TBL] [Abstract][Full Text] [Related]
11. Evidence for distinct calcium channel agonist and antagonist binding sites in intact cultured embryonic chick ventricular cells.
Lee RT; Smith TW; Marsh JD
Circ Res; 1987 May; 60(5):683-91. PubMed ID: 2439230
[TBL] [Abstract][Full Text] [Related]
12. Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.
Salomone S; Godfraind T
Br J Pharmacol; 1993 May; 109(1):100-6. PubMed ID: 8495233
[TBL] [Abstract][Full Text] [Related]
13. Functional dihydropyridine binding site associated with slow calcium channel in rat cultured neurones.
Maloteaux JM; Octave JN; Laterre EC
Neurosci Lett; 1988 Apr; 87(1-2):168-72. PubMed ID: 2454427
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
Dunn SM; Bladen C
Biochemistry; 1991 Jun; 30(23):5716-21. PubMed ID: 1645998
[TBL] [Abstract][Full Text] [Related]
15. The effects of strychnine on the regulation of voltage-dependent calcium channels by dihydropyridines in brain and heart.
O'Neill SK; Bolger GT
Pharmacol Biochem Behav; 1990 Apr; 35(4):833-40. PubMed ID: 1693213
[TBL] [Abstract][Full Text] [Related]
16. Molecular approach to the calcium channel.
Glossmann H; Ferry DR; Goll A; Linn T
Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
[TBL] [Abstract][Full Text] [Related]
17. [3H]BAY K 8644, a 1,4-dihydropyridine Ca++ channel activator: characteristics of binding to high and low affinity sites in cardiac membranes.
Sarmiento JG; Shrikhande AV; Janis RA; Triggle DJ
J Pharmacol Exp Ther; 1987 Apr; 241(1):140-6. PubMed ID: 2437286
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
Zheng W; Rampe D; Triggle DJ
Mol Pharmacol; 1991 Nov; 40(5):734-41. PubMed ID: 1719369
[TBL] [Abstract][Full Text] [Related]
19. Interaction of pinaverium (a quaternary ammonium compound) with 1,4-dihydropyridine binding sites in rat ileum smooth muscle.
Feron O; Wibo M; Christen MO; Godfraind T
Br J Pharmacol; 1992 Feb; 105(2):480-4. PubMed ID: 1313732
[TBL] [Abstract][Full Text] [Related]
20. Regional distribution of calcium channel ligand (1,4-dihydropyridine) binding sites and 45Ca2+ uptake processes in rat brain.
Skattebøl A; Triggle DJ
Biochem Pharmacol; 1987 Dec; 36(23):4163-6. PubMed ID: 2446630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
